PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsoral candidiasis
MeSH D002180 - oral candidiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002177:Candidiasis
29 Companies
7 Drugs
$
Success rate
D009059:Mouth diseases
78 Companies
13 Drugs
$
Success rate
D002180: 
Oral candidiasis
103 Companies
11 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MChlorhexidine Avagard  2001-06-07   
Chlorhexidine Peridex  1986-08-13   
Chlorhexidine Soluprep 2029-07-26 2018-08-08   
AAIPharmaKetoconazole Ketoconazole  1999-07-27   
Accord HealthcareItraconazole Itraconazole  2016-05-26   
Posaconazole Posaconazole AHCL  2019-07-25   
Posaconazole Posaconazole Accord  2019-07-25   
Aet PharmaPosaconazole Posaconazole  2021-02-01   
AkornNystatin Nystatin  1994-02-28   
Alembic PharmaceuticalsItraconazole Itraconazole  2016-12-13   
Nystatin, Triamcinolone Nystatin Triamcinolone  2021-03-31   
Alkem LaboratoriesItraconazole Itraconazole  2017-06-12   
AllerganClotrimazole, Betamethasone Clotrimazole Betamethasone  2002-08-02   
Nystatin Nystatin  1982-01-01   
Posaconazole Posaconazole  2022-11-30   
AlmirallKetoconazole Xolegel  2006-07-28   
AlpharmaNystatin Mykinac  1982-07-29   
Nystatin Nystatin  1985-10-29   
Nystatin, Triamcinolone Nystatin Triamcinolone  1988-12-20   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
78%
7/9
Phase 3
67%
12/18
Approved: 8Overall Success rate: 52%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
3M
Chlorhexidine,
Chlorhexidine gluconate
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use